Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Farmers merchants
Loading...
You are here:  Home  >  Biotech  >  Current Article

Inogen beats expectations and stock soars

By   /   Tuesday, November 5th, 2019  /   No Comments

    Print       Email
Revenue and net income declined for Goleta-based Inogen in the third quarter, but the results outpaced analyst expectations, sending the stock up 9.5 percent in after-hours trading to $65. The oxygen concentrator developer reported $91.8 million in revenue, edging past average analyst estimates, while earnings per share of 31 cents blew past forecasts of 23…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

Apeel adding facilities in Mexico, Peru and Netherlands

Read More →